FOLEX PFS Drug Patent Profile
Which patents cover Folex Pfs, and what generic alternatives are available?
Folex Pfs is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in FOLEX PFS is methotrexate sodium. There is one drug master file entry for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Folex Pfs
A generic version of FOLEX PFS was approved as methotrexate sodium by HIKMA on September 16th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FOLEX PFS?
- What are the global sales for FOLEX PFS?
- What is Average Wholesale Price for FOLEX PFS?
Summary for FOLEX PFS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Patent Applications: | 3,190 |
| DailyMed Link: | FOLEX PFS at DailyMed |
US Patents and Regulatory Information for FOLEX PFS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | FOLEX PFS | methotrexate sodium | INJECTABLE;INJECTION | 081242-001 | Aug 23, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | FOLEX PFS | methotrexate sodium | INJECTABLE;INJECTION | 089180-001 | Jan 3, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
